Artificial Intelligence used to design brand new viruses

NewsSuite newsroom brief · 46d ago · 1 min read · via bbc.co.uk

Scientists made 16 successful viruses that had their genetic code designed by artificial intelligence.

The creation of 16 new viruses using artificial intelligence to design their genetic code is a significant development that raises both intriguing and concerning questions. On one hand, this achievement showcases the rapid progress being made in the field of AI and its potential applications in biotechnology. The ability to design and create new viruses with specific characteristics could lead to breakthroughs in fields such as medicine, where viruses can be engineered to target and destroy cancer cells or deliver therapeutic genes.

However, the creation of new viruses also raises concerns about biosafety and the potential risks of these artificially designed pathogens being misused. The fact that AI can be used to design viruses with unknown properties and potential effects on human health and the environment is a worrying prospect. This development highlights the need for strict regulations and safeguards to prevent the misuse of this technology. It also underscores the importance of ongoing research into the ethics and governance of AI applications in biotechnology.

As this technology continues to evolve, it's essential to monitor how it's being developed and used. Key areas to watch include the implementation of safety protocols and regulations, as well as the development of countermeasures to mitigate potential risks. Additionally, the scientific community and policymakers will need to engage in ongoing discussions about the ethics and implications of using AI to design new biological agents. The intersection of AI, biotechnology, and biosafety is likely to be a critical area of focus in the years to come.

Originally reported by bbc.co.uk. NewsSuite adds analysis for general news readers.

Originally reported by bbc.co.uk. NewsSuite curates and briefs the general news stories that matter. Our editorial policy →
Get the daily general signal:

More from NewsSuite

Across the eCorp newsroom network

Part of the eCorp network